Notice of the General Office of the National Health Commission on Issuing the Guiding Principles for the Clinical Application of Novel Antitumor Drugs (2023 Edition)

This document issues the updated 2023 edition of the guiding principles for the clinical application of novel antitumor drugs, replacing the 2022 edition, to further standardize clinical use. It requires all provincial health commissions to implement the principles.